HomeBiotech

Biotech

Chimerix Announces Pricing of Public Offering of Common Stock

Chimerix Announces Pricing of Public Offering of Common Stock

January 20, 2021

Fortress Biotech, Inc. Investors: Last Days to Participate Actively in the Class Action Lawsuit; Portnoy Law Firm

Fortress Biotech, Inc. Investors: Last Days to Participate Actively in the Class Action Lawsuit; Portnoy Law Firm

January 20, 2021

Oncocyte Announces $25 Million Registered Offering

Oncocyte Announces $25 Million Registered Offering

January 20, 2021

Information on the Total Number of Voting Rights and Shares (Articles 15 of the Law of 2 May 2007)

Information on the Total Number of Voting Rights and Shares (Articles 15 of the Law of 2 May 2007)

January 20, 2021

SHAREHOLDER ALERT: WeissLaw LLP Reminds ALSK, WDR, CBLI and WTRE Shareholders About Its Ongoing Investigations

SHAREHOLDER ALERT: WeissLaw LLP Reminds ALSK, WDR, CBLI and WTRE Shareholders About Its Ongoing Investigations

January 20, 2021

Cocrystal Pharma (COCP) Completes Research Obligations With Merck

Cocrystal Pharma (COCP) Completes Research Obligations With Merck

January 20, 2021

Bausch Health (BHC) Dry Eye Treatment Study Enrollment Complete

Bausch Health (BHC) Dry Eye Treatment Study Enrollment Complete

January 20, 2021

Biotech Stock Roundup: ALXN Pauses Study, ACRS & GRTS Surge, & Other Updates

Biotech Stock Roundup: ALXN Pauses Study, ACRS & GRTS Surge, & Other Updates

January 20, 2021

Aclaris (ACRS) Up on Preliminary Data for MK2 Inhibitor in RA

Aclaris (ACRS) Up on Preliminary Data for MK2 Inhibitor in RA

January 20, 2021

CohBar to Present at the 3rd Annual Longevity Therapeutics Conference

CohBar to Present at the 3rd Annual Longevity Therapeutics Conference

January 20, 2021

« 1 … 650 651 652 653 654 … 692 »